Why Invest

BIOHARVEST IS THE INVENTOR OF BOTANICAL SYNTHESIS – THE PROCESS OF ISOLATING AND MAXIMIZING THE POTENCY OF PHYTO-NUTRIENTS/MEDICINAL COMPOUNDS FROM PLANTS FOR COMMERCIAL APPLICATIONS BY GROWING ONLY PLANT CELLS WITHOUT GROWING THE PLANT.

 

Chip image

Breakthrough Technology

Bring Life-changing Compounds To Commercial Markets

Beaker image

Mature Technology

Established Manufacturing Operations with Low Cost of Capita

Signature image

Expansive CDMO Opportunity

Four commercial contracts and robust deal pipeline

 

Heart pulse image

Successful D2C Health & Wellness Products Division

Recurring Revenue Subscription business
Validated Botanical Synthesis Technology

Dolar image

Attractive Operating Models For CDMO and Consumer Divisions

Provides Significant Optionality

TWO COMPLEMENTARY GROWTH ENGINES

Providing Validation For Botanical Synthesis And Strategic Optionality.

Detailed slider

OUR DISRUPTIVE CATEGORY PLAYBOOK ACCESSES MAJOR BILLION $ CATEGORIES

gradient separator

                      CDMO SERVICES DIVISION                      

CURRENT CDMO CONTRACTS IN TOP FOUR TARGET MARKETS

THE CDMO SALES FUNNEL: CURRENT CUSTOMER PROGRESS

BOTANICAL SYNTHESIS LAB-TO-CUSTOMER PROCESS IN FULL EFFECT

Customer progress chart

BHST INVESTMENT HIGHLIGHTS

Fully Funded due to successful ~$20M Q4 2025 Financing

Expanding current 20-25 tons production capacity to new capacity of ~50 tons by Q2-2027 and ~100 tons by end of 2028

D2C products division with over $32M of TTM Revenue over 85,000 active customers

Scalable CDMO platform with numerous signed customers progressing through development